Trials / Completed
CompletedNCT04505228
The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia
The Personalized Chinese Herb Formulas Are Evaluated for Their Effectiveness to Relieve Symptoms in Hypertensive Bradyarrhythmia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Jun Xiao · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.
Detailed description
To test the effect of Chinese herb against the hypertensive heart disease, we designed this randomized controlled clinical trial. 72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. 2 weeks after treatment, all the symptoms were graded again.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Safflower (Carthamus Tinctorius) IgG4 | Serum | Allergy | The designed Chinese herb formulas |
| DRUG | Atropine Sulfate | The basic treatment for heart disease |
Timeline
- Start date
- 2020-01-20
- Primary completion
- 2020-03-20
- Completion
- 2020-06-20
- First posted
- 2020-08-10
- Last updated
- 2020-08-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04505228. Inclusion in this directory is not an endorsement.